[Normal tissue tolerance to external beam radiation therapy: brain and hypophysis].
Anticancer treatments-induced central nervous system neurotoxicity has become a major problem in recent years. Real advances in therapeutic results for cancer treatments have improved patients' survival. Nowadays, central nervous system radiation therapy is widely prescribed, both for palliative and curative treatments in the management of malignant or benign tumors. Recent data on tolerance of normal central nervous system to radiation therapy are reviewed here, early and delayed radiation-induced effects are described and dose recommendations are suggested for clinical practice.
Haberer
S
S
Service d'Oncologie Radiothérapique, AP-HP, Groupe Hospitalier Pitié-Salpêtrière, 47-83 Boulevard de l'Hôpital, 75651 Paris cedex 13, France.
Assouline
A
A
Mazeron
J-J
JJ
D000016:Abnormalities, Radiation-Induced / Q000209:etiology*; D001921:Brain / Q000473:pathology / Q000528:radiation effects*; D002490:Central Nervous System / Q000033:anatomy & histology / Q000528:radiation effects; D016543:Central Nervous System Neoplasms / Q000532:radiotherapy; D002560:Cerebrovascular Circulation / Q000528:radiation effects; D003072:Cognition Disorders / Q000000981:diagnostic imaging; D003221:Confusion / Q000000981:diagnostic imaging; D004700:Endocrine System Diseases / Q000000981:diagnostic imaging; D006801:Humans; D008569:Memory Disorders / Q000000981:diagnostic imaging; D009336:Necrosis / Q000000981:diagnostic imaging; D009369:Neoplasms / Q000532:radiotherapy; D010902:Pituitary Gland / Q000528:radiation effects*; D011836:Radiation Tolerance; D011877:Radionuclide Imaging; D011878:Radiotherapy / Q000009:adverse effects* / Q000379:methods*